MiNK Therapeutics Statistics
NASDAQ: INKTHealthcareBiotechnologyUSD
11.00-0.42 (-3.68%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
MiNK Therapeutics by the numbers
MiNK Therapeutics has a market capitalization of $56.1 million based on 5.10M shares outstanding. With trailing EPS of $-2.39, MiNK Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 5.3% below its 50-day average and 3.6% below its 200-day average.
Average daily trading volume is 13.80K shares, or about $151,833 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
INKT valuation vs. peer median
| Metric | INKT | Peer median | Difference |
|---|---|---|---|
| Market cap | $56.13M | $56.01M | +0% |
| Avg. volume | 13.80K | 183.75K | -92% |
Peer median across 8 companies: GUTS, ATHE, CNTB, ALDX, LONA, ACET, BOLD, IBIO.
Valuation
- Market cap
- $56.13M
- EPS (TTM)
- $-2.39
- Shares outstanding
- 5.10M
Price and trading
- Previous close
- 11.42
- Open
- 11.56
- Day range
- 10.96 – 11.56
- 52-week range
- 8.48 – 16.93
- 52-week change
- -24.61%
- Beta
- —
- Volume
- 10.26K
- Average volume
- 13.80K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 13, 2026
Additional statistics
- Market Cap
- 56.13M
- Forward Pe
- -4.16
- Eps
- -2.39
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 16.93
- Week52 Low
- 8.48
- Avg Volume
- 13,803.00
- Shares Outstanding
- 5.10M
- Ma50
- 11.61
- Ma200
- 11.42
- Earnings Date
- Aug 13, 2026
- Pct From52w High
- -35.02%
- Pct From52w Low
- 29.72%